Evidence map›Paper›PMID 21445304›Full record

ArticlePloS one2011

Titanium salan complexes displays strong antitumor properties in vitro and in vivo in mice.

Timo A Immel, Ulrich Groth, Thomas Huhn, Peter Öhlschläger

Abstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Mapping the Landscape of Global Anticancer Organometallics Research: A Systematic Review.Medicinal chemistry (Shariqah (United Arab Emirates)) · 2025
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Hydrolytically Stable and Cytotoxic [ONOInorganic chemistry · 2022
    Article
  7. Article
  8. Synthesis of asymmetrical diaminobis(alkoxo)-bisphenol compounds and their CDalton transactions (Cambridge, England : 2003) · 2021
    Article
  9. Article
  10. RacemicRSC advances · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cytotoxicity of a Ti(IV) compound is independent of serum proteins.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Timo A ImmelDepartment of Chemistry and Konstanz Research School Chemical Biology, University of Konstanz, Konstanz, Germany.
Ulrich Groth
Thomas Huhn
Peter Öhlschläger

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The anticancer activity of titanium complexes has been known since the groundbreaking studies of Köpf and Köpf-Maier on titanocen dichloride. Unfortunately, possibly due to their fast hydrolysis, derivatives of titanocen dichloride failed in clinical studies. Recently, the new family of titanium salan complexes containing tetradentate ONNO ligands with anti-cancer properties has been discovered. These salan complexes are much more stabile in aqueous media. In this study we describe the biological activity of two titanium salan complexes in a mouse model of cervical cancer. High efficiency of this promising complex family was demonstrated for the first time in vivo. From these data we conclude that titanium salan complexes display very strong antitumor properties exhibiting only minor side effects. Our results may influence the chemotherapy with metallo therapeutics in the future.

Indexed as

AnimalsAntineoplastic AgentsDisease Models, AnimalFemaleInhibitory Concentration 50MiceTitaniumUterine Cervical NeoplasmsAntineoplastic AgentsTitanium

Identifiers

PMID21445304
PMCPMC3061874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.